[HTML][HTML] Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation

P Heesen, G Schelling, M Birbaumer, R Jäger, B Bode… - Cancers, 2024 - mdpi.com
Simple Summary This study looks at how combining real-world/time data/evidence
(RWTD/E) with traditional clinical studies (known as randomized controlled trials) can …

[HTML][HTML] Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome

TTAF Obergfell, KN Nydegger, P Heesen, G Schelling… - Cancers, 2024 - mdpi.com
Simple Summary In this study, we aimed to understand the association between two types of
surgeries on sarcoma outcomes: surgeries that were planned with a clear understanding of …

A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial Results

A Childs, C Gerrand, B Brennan, R Young, KS Rankin… - Cancers, 2024 - mdpi.com
Simple Summary Treatment for osteosarcoma (OS) has remained largely unchanged over
the past 25 years. This is due in part to the low incidence of the disease, which makes the …

[HTML][HTML] Beyond the sarcoma center: establishing the Sarcoma HASM network—a Hub and Spoke Model network for global integrated and precision care

B Fuchs, A Gronchi - ESMO open, 2024 - Elsevier
Highlights•Proposes the HASM to improve sarcoma care accessibility and coordination.•
Integrates digital platforms for real-time/real-world data exchange and advanced predictive …

Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data

M Schärer, P Heesen, B Bode-Lesniewska, G Studer… - Cancers, 2023 - mdpi.com
Simple Summary Understanding the time it takes for sarcoma patients to start treatment after
their diagnosis is essential, as a rapid onset of therapy could mean better survival chances …